PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Name | miRBASE accession |
---|---|
mmu-miR-23a-3p
|
MIMAT0000532 |
mmu-miR-23b-3p
|
MIMAT0000125 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_64960705 | 5.19 |
ENSMUST00000165536.8
|
Klf3
|
Kruppel-like factor 3 (basic) |
chrX_-_47543029 | 4.66 |
ENSMUST00000114958.8
|
Elf4
|
E74-like factor 4 (ets domain transcription factor) |
chr8_+_57964921 | 4.36 |
ENSMUST00000067925.8
|
Hmgb2
|
high mobility group box 2 |
chr17_-_32074754 | 3.89 |
ENSMUST00000024839.6
|
Sik1
|
salt inducible kinase 1 |
chr10_-_117681864 | 3.86 |
ENSMUST00000064667.9
|
Rap1b
|
RAS related protein 1b |
chr13_-_111945499 | 3.52 |
ENSMUST00000109267.9
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1 |
chr3_-_83947416 | 3.09 |
ENSMUST00000192095.6
ENSMUST00000191758.6 ENSMUST00000052342.9 |
Tmem131l
|
transmembrane 131 like |
chr15_-_5273659 | 3.04 |
ENSMUST00000047379.15
|
Ptger4
|
prostaglandin E receptor 4 (subtype EP4) |
chr6_+_17463748 | 2.97 |
ENSMUST00000115443.8
|
Met
|
met proto-oncogene |
chr7_+_79836581 | 2.96 |
ENSMUST00000032754.9
|
Sema4b
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr8_-_116434517 | 2.89 |
ENSMUST00000109104.2
|
Maf
|
avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr3_+_14951478 | 2.74 |
ENSMUST00000029078.9
|
Car2
|
carbonic anhydrase 2 |
chr5_-_96309849 | 2.64 |
ENSMUST00000155901.8
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr6_-_39183712 | 2.51 |
ENSMUST00000002305.9
|
Kdm7a
|
lysine (K)-specific demethylase 7A |
chr5_-_136596299 | 2.45 |
ENSMUST00000004097.16
|
Cux1
|
cut-like homeobox 1 |
chr3_-_19365431 | 2.32 |
ENSMUST00000099195.10
|
Pde7a
|
phosphodiesterase 7A |
chr4_+_129714494 | 2.30 |
ENSMUST00000165853.2
|
Ptp4a2
|
protein tyrosine phosphatase 4a2 |
chr3_-_9069745 | 2.23 |
ENSMUST00000120143.8
|
Tpd52
|
tumor protein D52 |
chr14_+_99283807 | 2.14 |
ENSMUST00000022656.8
|
Bora
|
bora, aurora kinase A activator |
chr11_-_53313950 | 2.12 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr16_+_14523696 | 2.05 |
ENSMUST00000023356.8
|
Snai2
|
snail family zinc finger 2 |
chr10_+_5543769 | 2.02 |
ENSMUST00000051809.10
|
Myct1
|
myc target 1 |
chr10_-_37014859 | 2.02 |
ENSMUST00000092584.6
|
Marcks
|
myristoylated alanine rich protein kinase C substrate |
chr8_-_48128164 | 2.01 |
ENSMUST00000080353.3
|
Ing2
|
inhibitor of growth family, member 2 |
chr9_-_14663689 | 2.00 |
ENSMUST00000061498.7
|
Fut4
|
fucosyltransferase 4 |
chr11_+_67061837 | 2.00 |
ENSMUST00000170159.8
|
Myh2
|
myosin, heavy polypeptide 2, skeletal muscle, adult |
chr16_+_24212284 | 1.99 |
ENSMUST00000038053.14
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma |
chr10_+_79824418 | 1.94 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr15_-_56557920 | 1.93 |
ENSMUST00000050544.8
|
Has2
|
hyaluronan synthase 2 |
chr17_-_52139693 | 1.91 |
ENSMUST00000144331.8
|
Satb1
|
special AT-rich sequence binding protein 1 |
chr2_-_144112700 | 1.91 |
ENSMUST00000110030.10
|
Snx5
|
sorting nexin 5 |
chr10_-_61288437 | 1.88 |
ENSMUST00000167087.2
ENSMUST00000020288.15 |
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr13_-_99027544 | 1.88 |
ENSMUST00000109399.9
|
Tnpo1
|
transportin 1 |
chr10_-_7831979 | 1.87 |
ENSMUST00000146444.8
|
Tab2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
chr14_-_20231871 | 1.87 |
ENSMUST00000024011.10
|
Kcnk5
|
potassium channel, subfamily K, member 5 |
chr3_-_105708632 | 1.86 |
ENSMUST00000090678.11
|
Rap1a
|
RAS-related protein 1a |
chr9_-_85209162 | 1.80 |
ENSMUST00000034802.15
|
Tent5a
|
terminal nucleotidyltransferase 5A |
chr11_+_67090878 | 1.80 |
ENSMUST00000124516.8
ENSMUST00000018637.15 ENSMUST00000129018.8 |
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr2_-_113588983 | 1.78 |
ENSMUST00000099575.4
|
Grem1
|
gremlin 1, DAN family BMP antagonist |
chr6_+_54793894 | 1.77 |
ENSMUST00000079869.13
|
Znrf2
|
zinc and ring finger 2 |
chr16_-_21982049 | 1.76 |
ENSMUST00000100052.11
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr2_-_75534985 | 1.75 |
ENSMUST00000102672.5
|
Nfe2l2
|
nuclear factor, erythroid derived 2, like 2 |
chr9_+_65536892 | 1.75 |
ENSMUST00000169003.8
|
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr12_+_76417040 | 1.75 |
ENSMUST00000042779.4
|
Zbtb1
|
zinc finger and BTB domain containing 1 |
chr12_+_111005768 | 1.73 |
ENSMUST00000084968.14
|
Rcor1
|
REST corepressor 1 |
chr9_-_116004265 | 1.73 |
ENSMUST00000061101.12
|
Tgfbr2
|
transforming growth factor, beta receptor II |
chr7_-_99508117 | 1.72 |
ENSMUST00000209032.2
ENSMUST00000036274.8 |
Spcs2
|
signal peptidase complex subunit 2 homolog (S. cerevisiae) |
chr15_+_59520199 | 1.67 |
ENSMUST00000067543.8
|
Trib1
|
tribbles pseudokinase 1 |
chr9_+_30941924 | 1.66 |
ENSMUST00000216649.2
ENSMUST00000115222.10 |
Zbtb44
|
zinc finger and BTB domain containing 44 |
chr3_+_51323383 | 1.65 |
ENSMUST00000029303.13
|
Naa15
|
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
chr1_-_178165223 | 1.64 |
ENSMUST00000037748.9
|
Hnrnpu
|
heterogeneous nuclear ribonucleoprotein U |
chr10_-_18891095 | 1.63 |
ENSMUST00000019997.11
|
Tnfaip3
|
tumor necrosis factor, alpha-induced protein 3 |
chr4_-_11007635 | 1.61 |
ENSMUST00000054776.4
|
Plekhf2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
chr7_-_115637970 | 1.60 |
ENSMUST00000166877.8
|
Sox6
|
SRY (sex determining region Y)-box 6 |
chr2_+_153583194 | 1.60 |
ENSMUST00000028981.9
|
Mapre1
|
microtubule-associated protein, RP/EB family, member 1 |
chr19_+_32734884 | 1.60 |
ENSMUST00000013807.8
|
Pten
|
phosphatase and tensin homolog |
chr6_-_39702381 | 1.59 |
ENSMUST00000002487.15
|
Braf
|
Braf transforming gene |
chr11_+_45946800 | 1.59 |
ENSMUST00000011400.8
|
Adam19
|
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
chr4_-_11386756 | 1.58 |
ENSMUST00000108313.8
ENSMUST00000108311.9 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr10_-_118705029 | 1.58 |
ENSMUST00000004281.10
|
Dyrk2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
chr2_-_104647041 | 1.53 |
ENSMUST00000117237.2
ENSMUST00000231375.2 |
Qser1
|
glutamine and serine rich 1 |
chr14_+_25694594 | 1.53 |
ENSMUST00000022419.7
|
Ppif
|
peptidylprolyl isomerase F (cyclophilin F) |
chr2_-_74489763 | 1.52 |
ENSMUST00000173623.2
ENSMUST00000001867.13 |
Evx2
|
even-skipped homeobox 2 |
chr15_-_51855073 | 1.52 |
ENSMUST00000022927.11
|
Rad21
|
RAD21 cohesin complex component |
chr10_+_53473032 | 1.52 |
ENSMUST00000020004.8
|
Asf1a
|
anti-silencing function 1A histone chaperone |
chr10_-_93146937 | 1.48 |
ENSMUST00000008542.12
|
Elk3
|
ELK3, member of ETS oncogene family |
chr4_-_34882917 | 1.47 |
ENSMUST00000098163.9
ENSMUST00000047950.6 |
Zfp292
|
zinc finger protein 292 |
chr5_+_97145533 | 1.47 |
ENSMUST00000112974.6
ENSMUST00000035635.10 |
Bmp2k
|
BMP2 inducible kinase |
chr4_+_8691303 | 1.46 |
ENSMUST00000051558.10
|
Chd7
|
chromodomain helicase DNA binding protein 7 |
chr18_+_56840813 | 1.45 |
ENSMUST00000025486.9
|
Lmnb1
|
lamin B1 |
chr6_-_51989456 | 1.45 |
ENSMUST00000078214.8
ENSMUST00000204778.3 |
Skap2
|
src family associated phosphoprotein 2 |
chr1_+_132243849 | 1.45 |
ENSMUST00000072177.14
ENSMUST00000082125.6 |
Nuak2
|
NUAK family, SNF1-like kinase, 2 |
chr15_+_80595486 | 1.43 |
ENSMUST00000067689.9
|
Tnrc6b
|
trinucleotide repeat containing 6b |
chr7_-_98790275 | 1.43 |
ENSMUST00000037968.10
|
Uvrag
|
UV radiation resistance associated gene |
chr2_-_84255602 | 1.42 |
ENSMUST00000074262.9
|
Calcrl
|
calcitonin receptor-like |
chr2_+_14234198 | 1.42 |
ENSMUST00000028045.4
|
Mrc1
|
mannose receptor, C type 1 |
chr15_+_84807582 | 1.41 |
ENSMUST00000165443.4
|
Nup50
|
nucleoporin 50 |
chr8_-_123425805 | 1.38 |
ENSMUST00000127984.9
|
Cbfa2t3
|
CBFA2/RUNX1 translocation partner 3 |
chr16_-_4031814 | 1.34 |
ENSMUST00000023165.9
|
Crebbp
|
CREB binding protein |
chr2_+_152068729 | 1.33 |
ENSMUST00000099224.10
ENSMUST00000124791.8 ENSMUST00000133119.2 |
Csnk2a1
|
casein kinase 2, alpha 1 polypeptide |
chr6_+_141194886 | 1.32 |
ENSMUST00000043259.10
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr18_-_82710859 | 1.32 |
ENSMUST00000182122.8
ENSMUST00000171071.9 |
Zfp236
|
zinc finger protein 236 |
chr4_-_133695204 | 1.31 |
ENSMUST00000100472.10
ENSMUST00000136327.2 |
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr6_+_38410848 | 1.30 |
ENSMUST00000160583.8
|
Ubn2
|
ubinuclein 2 |
chr13_+_24985640 | 1.28 |
ENSMUST00000019276.12
|
BC005537
|
cDNA sequence BC005537 |
chr11_+_53660834 | 1.27 |
ENSMUST00000108920.10
ENSMUST00000140866.9 ENSMUST00000108922.9 |
Irf1
|
interferon regulatory factor 1 |
chr16_-_31898088 | 1.26 |
ENSMUST00000023467.9
|
Pak2
|
p21 (RAC1) activated kinase 2 |
chr9_+_110361561 | 1.26 |
ENSMUST00000153838.8
|
Setd2
|
SET domain containing 2 |
chr13_+_94194269 | 1.25 |
ENSMUST00000054274.8
|
Lhfpl2
|
lipoma HMGIC fusion partner-like 2 |
chr1_-_64776890 | 1.25 |
ENSMUST00000116133.4
ENSMUST00000063982.7 |
Fzd5
|
frizzled class receptor 5 |
chr11_-_100713348 | 1.23 |
ENSMUST00000107358.9
|
Stat5b
|
signal transducer and activator of transcription 5B |
chr4_+_15265798 | 1.20 |
ENSMUST00000062684.9
|
Tmem64
|
transmembrane protein 64 |
chr2_-_33321306 | 1.19 |
ENSMUST00000113158.8
|
Zbtb34
|
zinc finger and BTB domain containing 34 |
chr7_+_122723365 | 1.19 |
ENSMUST00000205514.2
ENSMUST00000094053.7 |
Tnrc6a
|
trinucleotide repeat containing 6a |
chr5_-_107437427 | 1.17 |
ENSMUST00000031224.15
|
Tgfbr3
|
transforming growth factor, beta receptor III |
chr11_-_106811507 | 1.15 |
ENSMUST00000103067.10
|
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr2_+_74522258 | 1.14 |
ENSMUST00000061745.5
|
Hoxd10
|
homeobox D10 |
chr14_+_65596070 | 1.13 |
ENSMUST00000066994.7
|
Zfp395
|
zinc finger protein 395 |
chr11_+_3152612 | 1.12 |
ENSMUST00000110049.8
|
Eif4enif1
|
eukaryotic translation initiation factor 4E nuclear import factor 1 |
chr13_+_95012107 | 1.11 |
ENSMUST00000022195.13
|
Otp
|
orthopedia homeobox |
chr8_-_73059104 | 1.10 |
ENSMUST00000075602.8
|
Gm10282
|
predicted pseudogene 10282 |
chr19_+_56385531 | 1.08 |
ENSMUST00000026062.10
|
Casp7
|
caspase 7 |
chr18_-_88912446 | 1.07 |
ENSMUST00000070116.12
ENSMUST00000125362.8 |
Socs6
|
suppressor of cytokine signaling 6 |
chr10_-_40018243 | 1.07 |
ENSMUST00000092566.8
ENSMUST00000213488.2 |
Slc16a10
|
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
chr16_+_45044678 | 1.04 |
ENSMUST00000102802.10
ENSMUST00000063654.6 |
Btla
|
B and T lymphocyte associated |
chr7_-_67022520 | 1.04 |
ENSMUST00000156690.8
ENSMUST00000107476.8 ENSMUST00000076325.12 ENSMUST00000032776.15 ENSMUST00000133074.2 |
Mef2a
|
myocyte enhancer factor 2A |
chr19_+_40883127 | 1.02 |
ENSMUST00000050092.7
|
Zfp518a
|
zinc finger protein 518A |
chr11_+_77107006 | 1.02 |
ENSMUST00000156488.8
ENSMUST00000037912.12 |
Ssh2
|
slingshot protein phosphatase 2 |
chr1_+_39940043 | 1.01 |
ENSMUST00000168431.7
ENSMUST00000163854.9 |
Map4k4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr1_+_59521583 | 1.01 |
ENSMUST00000114246.4
|
Fzd7
|
frizzled class receptor 7 |
chr18_+_73706115 | 1.01 |
ENSMUST00000091852.5
|
Mex3c
|
mex3 RNA binding family member C |
chr13_-_104057016 | 1.00 |
ENSMUST00000022222.12
|
Erbin
|
Erbb2 interacting protein |
chr10_+_84938452 | 0.99 |
ENSMUST00000095383.6
|
Tmem263
|
transmembrane protein 263 |
chr19_+_21755689 | 0.98 |
ENSMUST00000096194.9
ENSMUST00000025663.8 |
Cemip2
|
cell migration inducing hyaluronidase 2 |
chr3_-_89820451 | 0.97 |
ENSMUST00000029559.7
ENSMUST00000197679.5 |
Il6ra
|
interleukin 6 receptor, alpha |
chr16_+_43960183 | 0.97 |
ENSMUST00000159514.8
ENSMUST00000161326.8 ENSMUST00000063520.15 ENSMUST00000063542.8 |
Naa50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr12_+_56742413 | 0.96 |
ENSMUST00000001538.10
|
Pax9
|
paired box 9 |
chr2_-_70655997 | 0.95 |
ENSMUST00000038584.9
|
Tlk1
|
tousled-like kinase 1 |
chr10_-_91007387 | 0.95 |
ENSMUST00000099355.12
ENSMUST00000105293.11 ENSMUST00000092219.14 ENSMUST00000020123.7 ENSMUST00000072239.14 |
Tmpo
|
thymopoietin |
chr1_-_151304191 | 0.94 |
ENSMUST00000064771.12
|
Swt1
|
SWT1 RNA endoribonuclease homolog (S. cerevisiae) |
chr2_+_160487801 | 0.93 |
ENSMUST00000109468.3
|
Top1
|
topoisomerase (DNA) I |
chr8_+_106363141 | 0.93 |
ENSMUST00000005841.16
|
Ctcf
|
CCCTC-binding factor |
chr10_-_116417333 | 0.92 |
ENSMUST00000218744.2
ENSMUST00000105267.8 ENSMUST00000105265.8 ENSMUST00000167706.8 ENSMUST00000168036.8 ENSMUST00000169921.8 ENSMUST00000020374.6 |
Cnot2
|
CCR4-NOT transcription complex, subunit 2 |
chr8_+_105067159 | 0.91 |
ENSMUST00000212948.2
ENSMUST00000034343.5 |
Cmtm3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr1_+_23801007 | 0.89 |
ENSMUST00000063663.6
|
B3gat2
|
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
chr13_+_44884740 | 0.88 |
ENSMUST00000173246.8
|
Jarid2
|
jumonji, AT rich interactive domain 2 |
chr9_-_32452885 | 0.86 |
ENSMUST00000016231.14
|
Fli1
|
Friend leukemia integration 1 |
chr11_-_84719779 | 0.86 |
ENSMUST00000047560.8
|
Dhrs11
|
dehydrogenase/reductase (SDR family) member 11 |
chr3_+_41510160 | 0.85 |
ENSMUST00000026865.15
ENSMUST00000194181.6 ENSMUST00000195846.6 |
Jade1
|
jade family PHD finger 1 |
chr1_+_53336229 | 0.81 |
ENSMUST00000027266.4
|
Ormdl1
|
ORM1-like 1 (S. cerevisiae) |
chr18_+_7869066 | 0.81 |
ENSMUST00000171486.8
ENSMUST00000170932.8 ENSMUST00000167020.8 |
Wac
|
WW domain containing adaptor with coiled-coil |
chr15_-_73056713 | 0.81 |
ENSMUST00000044113.12
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr6_-_83418656 | 0.81 |
ENSMUST00000089622.11
|
Tet3
|
tet methylcytosine dioxygenase 3 |
chr8_-_85414528 | 0.80 |
ENSMUST00000001975.6
|
Nacc1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
chr6_-_3968365 | 0.79 |
ENSMUST00000031674.11
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr16_+_26281885 | 0.78 |
ENSMUST00000161053.8
ENSMUST00000115302.2 |
Cldn16
|
claudin 16 |
chr5_+_145104011 | 0.78 |
ENSMUST00000160629.8
ENSMUST00000070487.12 ENSMUST00000160422.8 ENSMUST00000162244.8 |
Cpsf4
|
cleavage and polyadenylation specific factor 4 |
chr17_+_56891973 | 0.77 |
ENSMUST00000182533.8
ENSMUST00000182800.8 ENSMUST00000095224.11 |
Safb
|
scaffold attachment factor B |
chr8_-_112603292 | 0.77 |
ENSMUST00000034431.3
|
Tmem170
|
transmembrane protein 170 |
chr11_-_79971750 | 0.76 |
ENSMUST00000103233.10
ENSMUST00000061283.15 |
Crlf3
|
cytokine receptor-like factor 3 |
chr11_+_103007054 | 0.76 |
ENSMUST00000053063.7
|
Hexim1
|
hexamethylene bis-acetamide inducible 1 |
chr4_+_124696336 | 0.76 |
ENSMUST00000138807.8
ENSMUST00000030723.3 |
Mtf1
|
metal response element binding transcription factor 1 |
chrX_+_41156713 | 0.76 |
ENSMUST00000115094.8
|
Xiap
|
X-linked inhibitor of apoptosis |
chr12_+_78795763 | 0.75 |
ENSMUST00000082024.7
|
Mpp5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
chr18_-_57108405 | 0.75 |
ENSMUST00000139243.9
ENSMUST00000025488.15 |
C330018D20Rik
|
RIKEN cDNA C330018D20 gene |
chr5_+_123280250 | 0.74 |
ENSMUST00000174836.8
ENSMUST00000163030.9 |
Setd1b
|
SET domain containing 1B |
chr3_+_16237371 | 0.74 |
ENSMUST00000108345.9
ENSMUST00000191774.6 ENSMUST00000108346.5 |
Ythdf3
|
YTH N6-methyladenosine RNA binding protein 3 |
chr3_-_95725944 | 0.74 |
ENSMUST00000200164.5
ENSMUST00000090791.8 ENSMUST00000197449.2 |
Rprd2
|
regulation of nuclear pre-mRNA domain containing 2 |
chr8_-_96215401 | 0.74 |
ENSMUST00000212214.2
ENSMUST00000056919.9 |
Csnk2a2
|
casein kinase 2, alpha prime polypeptide |
chr1_-_52539395 | 0.74 |
ENSMUST00000186764.7
|
Nab1
|
Ngfi-A binding protein 1 |
chr19_-_47452840 | 0.73 |
ENSMUST00000081619.10
|
Sh3pxd2a
|
SH3 and PX domains 2A |
chr3_+_142236086 | 0.73 |
ENSMUST00000171263.8
ENSMUST00000045097.11 |
Gbp7
|
guanylate binding protein 7 |
chr19_-_60779077 | 0.73 |
ENSMUST00000025955.8
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A |
chr11_+_44508137 | 0.73 |
ENSMUST00000109268.2
ENSMUST00000101326.10 ENSMUST00000081265.12 |
Ebf1
|
early B cell factor 1 |
chr8_+_36054919 | 0.73 |
ENSMUST00000037666.6
|
Mfhas1
|
malignant fibrous histiocytoma amplified sequence 1 |
chr1_-_181669891 | 0.71 |
ENSMUST00000193028.2
ENSMUST00000191878.6 ENSMUST00000005003.12 |
Lbr
|
lamin B receptor |
chr11_+_96209093 | 0.71 |
ENSMUST00000049241.9
|
Hoxb4
|
homeobox B4 |
chr16_+_31482745 | 0.71 |
ENSMUST00000100001.10
ENSMUST00000064477.14 |
Dlg1
|
discs large MAGUK scaffold protein 1 |
chr9_+_44410417 | 0.70 |
ENSMUST00000074989.7
ENSMUST00000218913.2 |
Bcl9l
|
B cell CLL/lymphoma 9-like |
chr1_+_4878046 | 0.69 |
ENSMUST00000027036.11
ENSMUST00000150971.8 ENSMUST00000119612.9 ENSMUST00000137887.8 ENSMUST00000115529.8 |
Lypla1
|
lysophospholipase 1 |
chr6_+_15720653 | 0.69 |
ENSMUST00000101663.10
ENSMUST00000190255.7 ENSMUST00000189359.7 ENSMUST00000125326.8 |
Mdfic
|
MyoD family inhibitor domain containing |
chr4_-_136563154 | 0.68 |
ENSMUST00000105846.9
ENSMUST00000059287.14 ENSMUST00000105845.9 |
Ephb2
|
Eph receptor B2 |
chr10_-_40759307 | 0.68 |
ENSMUST00000044166.9
|
Cdc40
|
cell division cycle 40 |
chr12_-_56581823 | 0.67 |
ENSMUST00000178477.9
|
Nkx2-1
|
NK2 homeobox 1 |
chr7_-_136916123 | 0.66 |
ENSMUST00000106118.10
ENSMUST00000168203.2 ENSMUST00000169486.9 ENSMUST00000033378.13 |
Ebf3
|
early B cell factor 3 |
chr17_-_85995680 | 0.66 |
ENSMUST00000024947.8
ENSMUST00000163568.4 |
Six2
|
sine oculis-related homeobox 2 |
chr12_+_110704378 | 0.66 |
ENSMUST00000193053.6
ENSMUST00000095410.8 |
Wdr20
|
WD repeat domain 20 |
chr8_+_47192767 | 0.66 |
ENSMUST00000034041.9
ENSMUST00000208507.2 ENSMUST00000207105.2 |
Irf2
|
interferon regulatory factor 2 |
chr2_+_29951859 | 0.65 |
ENSMUST00000102866.10
|
Set
|
SET nuclear oncogene |
chr1_-_80318197 | 0.65 |
ENSMUST00000163119.8
|
Cul3
|
cullin 3 |
chr18_+_36414122 | 0.65 |
ENSMUST00000051301.6
|
Pura
|
purine rich element binding protein A |
chr19_+_36903471 | 0.63 |
ENSMUST00000099494.4
|
Btaf1
|
B-TFIID TATA-box binding protein associated factor 1 |
chr17_-_71158052 | 0.63 |
ENSMUST00000186358.6
|
Tgif1
|
TGFB-induced factor homeobox 1 |
chr9_+_72714156 | 0.63 |
ENSMUST00000055535.9
|
Prtg
|
protogenin |
chr3_-_86455575 | 0.62 |
ENSMUST00000077524.4
|
Mab21l2
|
mab-21-like 2 |
chr1_-_74990821 | 0.62 |
ENSMUST00000164097.4
|
Ihh
|
Indian hedgehog |
chr5_+_115769960 | 0.62 |
ENSMUST00000031492.15
|
Rab35
|
RAB35, member RAS oncogene family |
chrX_-_51254129 | 0.60 |
ENSMUST00000033450.3
|
Gpc4
|
glypican 4 |
chr6_+_83092476 | 0.59 |
ENSMUST00000032114.8
|
Mogs
|
mannosyl-oligosaccharide glucosidase |
chr2_-_34803988 | 0.58 |
ENSMUST00000028232.7
ENSMUST00000202907.2 |
Phf19
|
PHD finger protein 19 |
chr10_-_4338032 | 0.58 |
ENSMUST00000100078.10
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr11_+_105183463 | 0.58 |
ENSMUST00000100335.10
ENSMUST00000021038.5 |
Mrc2
|
mannose receptor, C type 2 |
chr5_+_32616187 | 0.57 |
ENSMUST00000015100.15
|
Ppp1cb
|
protein phosphatase 1 catalytic subunit beta |
chr5_+_103902020 | 0.57 |
ENSMUST00000054979.10
|
Aff1
|
AF4/FMR2 family, member 1 |
chr13_-_46118433 | 0.57 |
ENSMUST00000167708.4
ENSMUST00000091628.11 ENSMUST00000180110.9 |
Atxn1
|
ataxin 1 |
chr16_-_50252703 | 0.57 |
ENSMUST00000066037.13
ENSMUST00000089399.11 ENSMUST00000089404.10 ENSMUST00000138166.8 |
Bbx
|
bobby sox HMG box containing |
chr4_+_129407374 | 0.57 |
ENSMUST00000062356.7
|
Marcksl1
|
MARCKS-like 1 |
chr16_-_85698679 | 0.56 |
ENSMUST00000023611.7
|
Adamts5
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
chr11_-_33113071 | 0.56 |
ENSMUST00000093201.13
ENSMUST00000101375.5 ENSMUST00000109354.10 ENSMUST00000075641.10 |
Npm1
|
nucleophosmin 1 |
chr12_-_73160181 | 0.55 |
ENSMUST00000043208.8
ENSMUST00000175693.3 |
Six4
|
sine oculis-related homeobox 4 |
chr2_+_146063841 | 0.55 |
ENSMUST00000089257.6
|
Insm1
|
insulinoma-associated 1 |
chr17_-_48144094 | 0.55 |
ENSMUST00000131971.2
ENSMUST00000129360.2 ENSMUST00000113280.8 ENSMUST00000132125.8 |
Mdfi
|
MyoD family inhibitor |
chr18_+_35904541 | 0.54 |
ENSMUST00000170693.9
ENSMUST00000237984.2 ENSMUST00000167406.2 |
Ube2d2a
|
ubiquitin-conjugating enzyme E2D 2A |
chr5_-_21156766 | 0.54 |
ENSMUST00000036489.10
|
Rsbn1l
|
round spermatid basic protein 1-like |
chr7_+_98352298 | 0.54 |
ENSMUST00000033009.16
|
Thap12
|
THAP domain containing 12 |
chr6_+_119456629 | 0.53 |
ENSMUST00000032094.7
|
Fbxl14
|
F-box and leucine-rich repeat protein 14 |
chrX_-_141749704 | 0.53 |
ENSMUST00000041317.3
|
Ammecr1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr8_-_91074971 | 0.53 |
ENSMUST00000109621.10
|
Tox3
|
TOX high mobility group box family member 3 |
chr5_-_52827015 | 0.53 |
ENSMUST00000031069.13
|
Sepsecs
|
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase |
chr9_+_100956734 | 0.52 |
ENSMUST00000085177.5
|
Msl2
|
MSL complex subunit 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:2000387 | negative regulation of integrin activation(GO:0033624) regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) negative regulation of eosinophil migration(GO:2000417) |
0.8 | 6.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 2.7 | GO:2000880 | dipeptide transmembrane transport(GO:0035442) regulation of oligopeptide transport(GO:0090088) regulation of dipeptide transport(GO:0090089) positive regulation of oligopeptide transport(GO:2000878) positive regulation of dipeptide transport(GO:2000880) regulation of dipeptide transmembrane transport(GO:2001148) positive regulation of dipeptide transmembrane transport(GO:2001150) |
0.7 | 2.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.6 | 1.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 2.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.6 | 1.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.6 | 6.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.8 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.6 | 1.8 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.6 | 1.7 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 1.7 | GO:0002649 | B cell tolerance induction(GO:0002514) regulation of tolerance induction to self antigen(GO:0002649) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.6 | 1.7 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.5 | 1.6 | GO:0002631 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.5 | 1.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 3.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 3.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 1.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 3.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.4 | 1.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 1.3 | GO:0060061 | Spemann organizer formation(GO:0060061) syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.4 | 1.6 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.4 | 1.2 | GO:0060938 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
0.4 | 4.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 1.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.4 | 1.5 | GO:1904009 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
0.4 | 1.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 1.3 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.3 | 1.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.3 | 0.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 1.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 3.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 1.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 1.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.9 | GO:0040030 | nucleosome positioning(GO:0016584) regulation of molecular function, epigenetic(GO:0040030) |
0.2 | 1.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.7 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.2 | 1.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.2 | 1.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 1.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.8 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 0.6 | GO:0006407 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) rRNA export from nucleus(GO:0006407) |
0.2 | 1.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.2 | 1.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 0.8 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 0.5 | GO:0031104 | dendrite regeneration(GO:0031104) |
0.2 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 1.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 2.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:1990428 | miRNA transport(GO:1990428) |
0.1 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 2.0 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.6 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.9 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 3.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 1.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 2.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.1 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.3 | GO:0061076 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.1 | 0.5 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.3 | GO:0003285 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
0.1 | 1.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 1.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 2.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 3.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.3 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 2.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 1.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 2.0 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.2 | GO:1904633 | glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
0.1 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 1.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.4 | GO:1902510 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 1.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 2.1 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) |
0.0 | 2.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 1.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.5 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 1.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.2 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 1.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.3 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.7 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 1.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 1.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 2.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:1902895 | lateral mesoderm development(GO:0048368) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0032377 | dolichol metabolic process(GO:0019348) regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.2 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 2.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.0 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) regulation of biomineral tissue development(GO:0070167) |
0.0 | 1.1 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 2.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.5 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.3 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 1.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 2.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 2.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 2.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.7 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.2 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.9 | GO:0097422 | extrinsic component of endosome membrane(GO:0031313) tubular endosome(GO:0097422) |
0.2 | 2.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 2.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 1.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 3.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.8 | GO:0005859 | muscle myosin complex(GO:0005859) myosin filament(GO:0032982) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 3.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 2.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 4.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 3.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 1.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 5.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 2.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 1.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.7 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 2.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 1.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.0 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.6 | 2.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.6 | 3.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 1.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 1.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 4.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 4.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 3.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.3 | 0.9 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.3 | 2.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.3 | 1.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.6 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 1.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 3.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 4.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 2.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 2.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 2.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 4.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0070540 | stearic acid binding(GO:0070540) |
0.0 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.0 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 2.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 1.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 2.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.6 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 1.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 6.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 1.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.8 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 6.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.5 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 1.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 5.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 5.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 4.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 2.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 4.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 2.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 3.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 5.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 3.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 3.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 3.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 2.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 2.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 3.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.8 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.4 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |